1
Clinical Trials associated with Prostate cancer DNA vaccine(Karolinska Institutet)DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and Electroporation in Patients With Relapsed Prostate Cancer. A Phase I/II Study
This study will assess the feasibility and safety of vaccination with increasing doses of xenogenic DNA administered intradermally in combination with electroporation in patients with relapse of prostate cancer. The DNA encodes prostate specific antigen (PSA) from Rhesus Macaque (Macaca mulatta), a protein that is 89% homologous to human PSA. The study will also assess the safety and functionality of the DERMA VAX™ (Cyto Pulse Sciences) DNA vaccine delivery system.
100 Clinical Results associated with Prostate cancer DNA vaccine(Karolinska Institutet)
100 Translational Medicine associated with Prostate cancer DNA vaccine(Karolinska Institutet)
100 Patents (Medical) associated with Prostate cancer DNA vaccine(Karolinska Institutet)
100 Deals associated with Prostate cancer DNA vaccine(Karolinska Institutet)